EpilepsyMAPENCT05741541
How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?
An observational study of Epilepsy, run by Hopital Nord Franche-Comte at 1 site in France.
Trial summary
The goal of this observationnal study is to identify the informative and educational needs of epilepsy patients to avoid interrupting the therapeutic pathway. The main question it aims to answer are : Identify the patient's expectations of a nurse specializing in epilepsy in the areas of information, predictive… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Epilepsy
- How many people
- 15 participants
- Where
- 1 siteFrance
- Study dates
- 24 Feb 2023to 29 Apr 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Epileptics patients over 18 prsenting eligiblity criteria and and whose diagnosis has been made for less than 6 months and coming from for consultation in the Hôpital Nord Franche-Comté
Who may be able to join
- Adult epileptic patients, over 18 years old
- Patients with focal or generalized epilepsy
- Patients affiliated or entitled to a social security scheme
- Patients who have received informed information about the study and who have co- signed, with the investigator, a non-objection to participation in the study
- Patients whose diagnosis has been made for at least 6 months
Who cannot join
- Patients with intellectual disabilities
- Minors
- Untreated patients, in remission
- Patients without affiliation to a social security scheme
- Patients under guardianship or curatorship
Trial locations and contacts
1 site in 1 country.
About this study
The goal of this observationnal study is to identify the informative and educational needs of epilepsy patients to avoid interrupting the therapeutic pathway.
The main question it aims to answer are :
Read more
- Identify the patient's expectations of a nurse specializing in epilepsy in the areas of information, predictive elements of good care and adaptation to their state of health
- Identify under-addressed or misunderstood themes
- Identify patient resources and interventions already in place
- Ensuring better continuity of care
- Improve the knowledge of patients and their relatives about the management of their pathology
After a consultation with the neurologist (as part of their usual follow-up), the participants will be referred to a nurse for a semi-directive, individual interview, lasting 30 minutes and composed of open and closed questions. The announcement of the diagnosis, the quality of life or the factors contributing to the difficulties and their repercussions on a daily basis will be discussed during the interview.
- Conditions
- Epilepsy
- Medical subject headings
- Epilepsy
What is being measured
The primary outcome is the main question the study is designed to answer.
Identify the informative and educational needs of epileptic patients to avoid disrupting the therapeutic course by an interview with an nurse.
Measured: At inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Feb 2023
- Study start24 Feb 2023
- Primary completion29 Mar 2023
- Study completion29 Apr 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EpilepsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hopital Nord Franche-Comte
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05741541
- Sponsor's protocol ID
- 2022-A02583-40
- Acronym
- MAPE
- Status last verified
- Feb 2023
- First submitted
- 14 Feb 2023
- Last updated
- 23 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?
- ClinicalTrials.gov ID
- NCT05741541
- Acronym / sponsor ID
- MAPE / 2022-A02583-40
- Conditions
- Epilepsy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 15 participants (actual)
- Lead sponsor
- Hopital Nord Franche-ComteUniversity, hospital or other
- Study start
- 24 Feb 2023 (actual)
- Primary completion
- 29 Mar 2023 (actual)
- Study completion
- 29 Apr 2023 (actual)
- First posted
- 23 Feb 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observationnal study is to identify the informative and educational needs of epilepsy patients to avoid interrupting the therapeutic pathway.
The main question it aims to answer are :
- Identify the patient's expectations of a nurse specializing in epilepsy in the areas of information, predictive elements of good care and adaptation to their state of health
- Identify under-addressed or misunderstood themes
- Identify patient resources and interventions already in place
- Ensuring better continuity of care
- Improve the knowledge of patients and their relatives about the management of their pathology
After a consultation with the neurologist (as part of their usual follow-up), the participants will be referred to a nurse for a semi-directive, individual interview, lasting 30 minutes and composed of open and closed questions. The announcement of the diagnosis, the quality of life or the factors contributing to the difficulties and their repercussions on a daily basis will be discussed during the interview.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Epileptics patients over 18 prsenting eligiblity criteria and and whose diagnosis has been made for less than 6 months and coming from for consultation in the Hôpital Nord Franche-Comté
Key inclusion criteria (5 listed)
- Adult epileptic patients, over 18 years old
- Patients with focal or generalized epilepsy
- Patients affiliated or entitled to a social security scheme
- Patients who have received informed information about the study and who have co- signed, with the investigator, a non-objection to participation in the study
- Patients whose diagnosis has been made for at least 6 months
Key exclusion criteria (5 listed)
- Patients with intellectual disabilities
- Minors
- Untreated patients, in remission
- Patients without affiliation to a social security scheme
- Patients under guardianship or curatorship
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Identify the informative and educational needs of epileptic patients to avoid disrupting the therapeutic course by an interview with an nurse.
Time frame: At inclusion
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jun 2023.
- Individual participant dataSharing planned: No
Related trials for Epilepsy
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Focal Seizure, Epilepsy
Not yet recruiting
Clinical Trial of SEEG for Drug-resistant Epilepsy
Drug-Resistant Epilepsy
RecruitingPhase 1
Study Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting Injectable.
Epilepsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Epilepsy, run by Hopital Nord Franche-Comte at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Identify the informative and educational needs of epileptic patients to avoid disrupting the therapeutic course by an interview with an nurse. (time frame: At inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2023; AzTrials last refreshed its copy on 7 Nov 2026.